Status: current, Defined. Date: 30-Nov 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1483051000168113 | fondaparinux sodium 5 mg / 0.4 mL injection, 0.4 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1483061000168110 | fondaparinux sodium 5 mg/0.4 mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| fondaparinux sodium 5 mg/0.4 mL injection, syringe | Is a | fondaparinux | true | Inferred relationship | Some | ||
| fondaparinux sodium 5 mg/0.4 mL injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| fondaparinux sodium 5 mg/0.4 mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| fondaparinux sodium 5 mg/0.4 mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 282099262 | |
| fondaparinux sodium 5 mg/0.4 mL injection, syringe | has Australian BoSS | fondaparinux sodium | true | Inferred relationship | Some | 282099261 | |
| fondaparinux sodium 5 mg/0.4 mL injection, syringe | has intended active ingredient | fondaparinux | true | Inferred relationship | Some | 282099261 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Arixtra 5 mg/0.4 mL injection, 0.4 mL syringe | Is a | True | fondaparinux sodium 5 mg/0.4 mL injection, syringe | Inferred relationship | Some | |
| fondaparinux sodium 5 mg/0.4 mL injection, 7 x 0.4 mL syringes | has MPUU | True | fondaparinux sodium 5 mg/0.4 mL injection, syringe | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR